Clinical Analysis of Gene Mutation in Adult Patients with B-ALL and Its Influence on Clinical Prognosis / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1867-1872, 2020.
Article
in Zh
| WPRIM
| ID: wpr-879985
Responsible library:
WPRO
ABSTRACT
OBJECTIVE@#To investigate the gene mutation in adult patients with B-ALL and its influence on clinical prognosis.@*METHODS@#Clinical data of 226 adult patients with B-ALL were retrospectively analyzed in the period from August 2011 to February 2018. The incidence of gene mutation in all patients were detected, and the influence of mutation gene on clinical prognosis were estimated. Cox regression model were used to evaluate the independent prognostic factors.@*RESULTS@#208 (92.04%) of 226 patients showed gene mutations, and the median mutation number was 2 (0-8). Among them, 54 cases (23.89%) showed 14 or more mutations. The top five mutation types of all patients were SF1, FAT1, MPL, PTPNII and N-RAS respectively. The median OS and median RFS times of 226 patients were 27.0 (5.5-84.0) months and 22.5 (0-81.0) months respectively. The OS and RFS times of Ph@*CONCLUSION@#Gene mutations are common in all adult B-ALL patients, and the clinical prognosis of patients with JAK and epigenetics-related signaling pathway mutations is worsen, while the WBC level closely relates to the clinical prognosis of the patients.
Full text:
1
Database:
WPRIM
Main subject:
Patients
/
Prognosis
/
Proportional Hazards Models
/
Retrospective Studies
/
Mutation
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
Zh
Journal:
Journal of Experimental Hematology
Year:
2020
Document type:
Article